Showing 6101-6110 of 9536 results for "".
- Anterios CEO to Present at Healthcare Conferencehttps://practicaldermatology.com/news/20130429-anterios_ceo_to_present_at_healthcare_conference/2459558/CEO and Founder of Anterios, Inc., Jon Edelson, MD, will be presenting at Needham & Company's 12th Annual Healthcare Conference in New York City on April 30, 2013. In other company news, Anterios also recently received an $8.5 million round of
- HydraSolve Cleared for Autologous Fat Transferhttps://practicaldermatology.com/news/20130425-hydrasolve_cleared_for_autologous_fat_transfer/2459559/The new Hydrasolve liposuction device has recently been FDA-cleared for autologous fat transfer, a first-of-its-kind indication in the liposuction realm. The new clearance enables clinicians to harvest and re-inject fat from the initial HydraSolve liposuction procedure for rejuvenations or augmentat
- Angela Bennett Appointed as La Roche-Posay VPhttps://practicaldermatology.com/news/20130418-angela_bennett_appointed_as_la_roche-posay_vp/2459561/L'Oréal USA named Angela Bennett the Vice President of La Roche-Posay. A graduate of Loyola University in Baltimore, MD where she earned a degree in Business Administration, Bennett brings a wealth of experience, having worked with many global brands and has established solid relationships wi
- Obagi Fate Uncertain as New Details Emergehttps://practicaldermatology.com/news/20130403-obagi_fate_uncertain_as_new_details_emerge/2459573/Following a bidding war with rival Merz Pharma Group, Valeant Pharmaceuticals appears set to acquire Obagi Medical Products. Valeant's original offer came in March, when the company announced that it would acquire Obagi at $19.75 per share, in a deal worth approximately $344 million. Then, in early
- Site Aims to Steer Patients to Physicians' Informationhttps://practicaldermatology.com/news/20130401-site_aims_to_steer_patients_to_physicians_information/2459577/Giving patients the proper information has always been important for physicians, and accessible handout literature has been the easiest ways to keep bad information out of their hands. But to keep pace with how quickly patients get their information, Vivacare allows physicians to enroll online free
- New Survey Finds Social Media is a Major Influence on Elective Surgeryhttps://practicaldermatology.com/news/20130327-new_survey_finds_social_media_is_a_major_influence_on_elective_surgery/2459578/Social media is leading consumers to have a more self-critical eye, according to a new survey by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). The annual poll of the organization's board-certified facial plastic surgeons found a 31 percent increase in requests for surge
- Valeant Pharmaceuticals to Acquire Obagi Medical Products for Approximately $344 Millionhttps://practicaldermatology.com/news/20130320-valeant_pharmaceuticals_to_acquire_obagi_medical_products_for_approximately_360_million/2459581/Valeant Pharmaceuticals has entered into an agreement to acquire Obagi Medical Products. The transaction values Obagi common stock at approximately $344 million and was unanimously approved by the Obagi Board of Directors. Under terms of the merger agreement, Valeant will commence a tender offer for
- On Match Day, AMA Calls for Additional Residency Positions to Address Physician Shortagehttps://practicaldermatology.com/news/20130319-on_match_day_ama_calls_for_additional_residency_positions_to_address_physician_shortage/2459585/A statement released by Jeremy A. Lazarus, M.D., President of the American Medical Association, is seeking to raise awareness about the physician shortage. "Today, on Match Day, thousands of medical students will learn where they will complete their graduate medical education (GME), known as reside
- Cynthia Nixon Partners with Galderma and the NRS to Raise Awareness for Rosaceahttps://practicaldermatology.com/news/20130314-cynthia_nixon_partners_with_galderma_and_the_nrs_to_raise_awareness_for_rosacea/2459591/Actress Cynthia Nixon recently joined with dermatologists Rick Fried, MD and Flor Mayoral, MD and a panel of other experts at the "Face to Face with Rosacea: Empowering Professionals and Patients" educational event at the AAD Meeting in Miami. Sponsored by Galderma in conjunction with the National R
- Investigational Injectable Found Safe, Effective for Submental Fathttps://practicaldermatology.com/news/20130311-investigational_injectable_found_safe_effective_for_submental_fat/2459596/An investigational injectable drug for the reduction of submental fat called ATX-101 from Kythera Biopharmaceuticals was found both safe and effective in new data presented at the AAD Meeting in Miami. In the open-label Phase IIIb study, interim results three months after the last ATX-101 treatment